Dew, I happened to meet with a person from Baxter this weekend. He is at high level position in business development.
I asked him about the strategy of Baxter on Transgenically produced plasma proteins. His response was, he never heard of it. He then asked me to give some back ground on these products. He also told me that they are looking for those kind of products. He never heard of GTCB nor Atryn!!!!
I gave him a slip with this information.
Do you really think people at GTCB are working enough to sell the product. If a business development person at Baxter, for whatever reason, never heard of Atryn, then what about other companies?
Do you really think Cox will deliver the goods required for the very survival of this company?
Best Regards,